The global DNA methylation surrogate LINE-1 methylation is correlated with MGMT promoter methylation and is a better prognostic factor for glioma
about
DNA Methylation Analysis: Choosing the Right MethodClinical Neuropathology practice guide 5-2015: MGMT methylation pyrosequencing in glioblastoma: unresolved issues and open questionsEpidemiologic and molecular prognostic review of glioblastomaGlobal analysis of DNA methylation by Methyl-Capture sequencing reveals epigenetic control of cisplatin resistance in ovarian cancer cellWhole blood DNA aberrant methylation in pancreatic adenocarcinoma shows association with the course of the disease: a pilot studyDisagreement between two common biomarkers of global DNA methylationMorphine induces redox-based changes in global DNA methylation and retrotransposon transcription by inhibition of excitatory amino acid transporter type 3-mediated cysteine uptake.Methylation-mediated gene silencing as biomarkers of gastric cancer: a review.LINE-1 induces hTERT and ensures telomere maintenance in tumour cell lines.Genome-wide methylation analyses in glioblastoma multiforme.The prognostic value of global DNA hypomethylation in cancer: a meta-analysisDNA methylation of stress-related genes and LINE-1 repetitive elements across the healthy human placenta.Long interspersed nuclear element ORF-1 protein promotes proliferation and resistance to chemotherapy in hepatocellular carcinoma.LINE-1 hypomethylation in gastric cancer, detected by bisulfite pyrosequencing, is associated with poor prognosisGlobal DNA methylation profiling reveals new insights into epigenetically deregulated protein coding and long noncoding RNAs in CLL.Improved results of LINE-1 methylation analysis in formalin-fixed, paraffin-embedded tissues with the application of a heating step during the DNA extraction process.Unraveling the glioma epigenome: from molecular mechanisms to novel biomarkers and therapeutic targets.MGMT testing for glioma in clinical laboratories: discordance with methylation analyses prevents the implementation of routine immunohistochemistry.Predictors of long-term survival in patients with glioblastoma multiforme: advancements from the last quarter century.Refined brain tumor diagnostics and stratified therapies: the requirement for a multidisciplinary approach.Using the molecular classification of glioblastoma to inform personalized treatment.Clinical implications of the LINE-1 methylation levels in patients with gastrointestinal cancer.DNA methylation variations are required for epithelial-to-mesenchymal transition induced by cancer-associated fibroblasts in prostate cancer cells.Isocitrate Dehydrogenase (IDH)1/2 Mutations as Prognostic Markers in Patients With GlioblastomasQuantitative metabolome analysis profiles activation of glutaminolysis in glioma with IDH1 mutation.A CpG island methylator phenotype in acute myeloid leukemia independent of IDH mutations and associated with a favorable outcome.LINE-1 methylation level and prognosis in pancreas cancer: pyrosequencing technology and literature review.Genomic vulnerability to LINE-1 hypomethylation is a potential determinant of the clinicogenetic features of multiple myeloma.Prognostic role of IDH mutations in gliomas: a meta-analysis of 55 observational studies.Tumoral LINE-1 hypomethylation is associated with poor survival of patients with intrahepatic cholangiocarcinomaLINE-1 methylation level and patient prognosis in a database of 208 hepatocellular carcinomas.Global DNA hypomethylation in leukocytes associated with glioma risk.Is the prognostic significance of O6-methylguanine- DNA methyltransferase promoter methylation equally important in glioblastomas of patients from different continents? A systematic review with meta-analysis.The prognosis of MGMT promoter methylation in glioblastoma patients of different race: a meta-analysis.Prognostic significance of IDH mutation in adult low-grade gliomas: a meta-analysis.Temporal stability of MGMT promoter methylation in glioblastoma patients undergoing STUPP protocol.Genome-wide methylation profiles in primary intracranial germ cell tumors indicate a primordial germ cell origin for germinomas.Methadone induces hypermethylation of human DNA.Prognostic significance of promoter CpG island hypermethylation and repetitive DNA hypomethylation in stage I lung adenocarcinoma.CpG island methylator phenotype of myelodysplastic syndrome identified through genome-wide profiling of DNA methylation and gene expression.
P2860
Q26769972-5D05058F-DAD7-45C6-932C-564AA4E7A850Q26795767-D746BAB0-4003-4C2E-B8A6-E7A765C61F1FQ28395302-21D78041-6A37-46F9-8BFE-C2BEDBE43A19Q28478564-3D55CD01-0A90-424C-9520-BFD807727CFAQ28729757-EDE0C363-143A-47DA-8E18-2015441770FDQ28833594-1B5B36FF-FCAE-426A-A3F3-C513A3A313FBQ30413204-5ECA0E11-16AF-4802-A8EC-2082A95EE6A9Q34168437-8E43ECB4-16AF-40B5-B4B9-69D54BBB0D67Q34468156-9E5CD358-BF33-4C87-AC51-BF2B80FB192AQ35107175-635C2757-8906-4869-BE38-4E491DA670A1Q35237505-C653AEF8-BA01-49A2-A536-BB67F9EAB93CQ35841693-4960B484-6660-42CE-BF22-EFF39A02FAFAQ36637698-CECF997B-9FE3-4EC3-9BE7-051BCBF43E76Q37298707-58F8CA96-96D6-4DBB-B502-4D58E7BEC395Q37336849-EBED5AB3-DB95-4F2A-A830-BEBF85A825D1Q37609842-4B649B4A-E423-4F19-9D40-A101398DA2C4Q37937061-916C414E-7CE2-46D1-B433-CD52142C3AF6Q38044236-76CC3878-8C02-44CC-82EA-0F9487751520Q38101368-0B5EC2B8-5F8D-4549-9439-9FB4394C3B02Q38108186-2DBE20C6-653C-4496-B23E-50E8AF3EB1EAQ38151582-49DB3052-CE3F-463A-8541-6B835C5E037FQ38154781-1C8EC117-516D-431F-A22B-DEE8062AE455Q38743845-AC7B10E5-2CAE-4ADC-B6A1-3D7ADA2094E3Q38843549-0A98995E-4F3A-498B-9A6F-9048A4C52662Q39018975-9E299523-9F20-4341-A5BA-45A272A46B11Q39028173-242AD8B9-F5E3-4572-9CA5-6C636FFFE15FQ39325725-983434C1-B6CC-44FF-A723-492055CF013DQ40914883-82F82514-0AEC-45B3-B798-9080E4990077Q41536288-A55F787F-6955-4086-845A-C98D77BD29C0Q41558823-53095AB6-1455-4232-B6FA-FD5ACD2A46FEQ41699788-B6CBE7FF-8B2E-4ED4-ADFC-145C447D812FQ42362659-A0B53613-999E-4616-B7AB-C8A6FF890AE3Q42364418-2F24088D-72CD-4373-B75C-B97CA6257D10Q45835773-1EE950D4-3174-4B9A-A632-DBE0D318C6D2Q45841104-06444A31-DFD5-400F-B973-3770C2FB50E8Q47770490-100A07F4-1A53-4E61-9D13-DBE67A433BB5Q48361757-0885DC12-DD05-4826-9FE5-C059760AA97FQ51335928-D34B1071-A8F1-4A0A-B097-BF9E2B2A5682Q54170652-6CA202E8-1710-4732-A28C-9602E57641F6Q54219654-8B0037B5-EB4E-4FDE-A482-45D1352CCB27
P2860
The global DNA methylation surrogate LINE-1 methylation is correlated with MGMT promoter methylation and is a better prognostic factor for glioma
description
2011 nî lūn-bûn
@nan
2011 թուականին հրատարակուած գիտական յօդուած
@hyw
2011 թվականին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
The global DNA methylation sur ...... r prognostic factor for glioma
@ast
The global DNA methylation sur ...... r prognostic factor for glioma
@en
The global DNA methylation sur ...... r prognostic factor for glioma
@nl
type
label
The global DNA methylation sur ...... r prognostic factor for glioma
@ast
The global DNA methylation sur ...... r prognostic factor for glioma
@en
The global DNA methylation sur ...... r prognostic factor for glioma
@nl
prefLabel
The global DNA methylation sur ...... r prognostic factor for glioma
@ast
The global DNA methylation sur ...... r prognostic factor for glioma
@en
The global DNA methylation sur ...... r prognostic factor for glioma
@nl
P2093
P2860
P3181
P1433
P1476
The global DNA methylation sur ...... r prognostic factor for glioma
@en
P2093
Atsushi Natsume
Fumiharu Ohka
Hiroki Namba
Hiroyuki Momota
Kazuya Motomura
Kenichiro Iwami
Kenji Wakai
Masazumi Fujii
Sayano Kinjo
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0023332
P407
P577
2011-01-01T00:00:00Z